ClinicalTrials.Veeva

Menu

Diagnostic Value of Hand Ultrasound Versus MRI in Rheumatoid Arthritis

S

Sohag University

Status

Unknown

Conditions

Patient's With Rheumatoid Arthritis

Treatments

Radiation: Ultrasound and MRI

Study type

Interventional

Funder types

Other

Identifiers

NCT04961853
Soh-Med-21-07-12

Details and patient eligibility

About

Rheumatoid arthritis (RA) is one of the most common autoimmune rheumatic diseases, affecting one in 100 individuals worldwide. It is considered a complex systemic multifactorial inflammatory process in which the immune system targets synovial joints and causes mild to severe joint destruction with extra-articular manifestations.

If left untreated, RA leads to deformity, considerable disability, and major comorbid conditions, including cardiovascular disease and increased mortality.

Early treatment with targeted therapies can alter long-term outcomes by minimizing disease activity, preventing joint damage and disability, and improving patients' quality of life.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult-onset disease.
  2. Patients who fulfill the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis.

Exclusion criteria

  1. Any patient with any collagen disease rather than Rheumatoid arthritis.
  2. Patients with joints deformities.
  3. Patient's with implanted metal clips or wires or artificial pacemaker.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Cases
Experimental group
Treatment:
Radiation: Ultrasound and MRI

Trial contacts and locations

1

Loading...

Central trial contact

Fady B A, resident; Nahla M A, assistant professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems